We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HK.WS
576
DELISTED
Halcon Resources Corporation
HK.WS
| $53K | ﹤0.01% |
103,830
| – | – |
|
577
Entergy
ETR
$50B
| $48K | ﹤0.01% |
1,214
-4,160
| -77% | -$161K |
|
578
Leggett & Platt
LEG
$1.31B
| $44K | ﹤0.01% |
1,000
| – | – |
|
579
3M
MMM
$94.3B
| $44K | ﹤0.01% |
240
| – | – |
|
|
TVPT
580
DELISTED
Travelport Worldwide Limited
TVPT
| $42K | ﹤0.01% |
2,594
-112
| -4% | -$1.55K |
|
581
Encompass Health
EHC
$12.4B
| $41K | ﹤0.01% |
903
-75
| -8% | -$3.21K |
|
582
Integer Holdings
ITGR
$4.26B
| $41K | ﹤0.01% |
729
-20
| -3% | -$1.01K |
|
583
Darden Restaurants
DRI
$24.4B
| $40K | ﹤0.01% |
469
-2,757
| -85% | -$261K |
|
584
Boston Beer
SAM
$1.92B
| $40K | ﹤0.01% |
211
+8
| +4% | +$1.47K |
|
585
Ciena
CIEN
$58.4B
| $39K | ﹤0.01% |
1,516
-179
| -11% | -$4.21K |
|
586
Phibro Animal Health
PAHC
$1.39B
| $39K | ﹤0.01% |
982
-51
| -5% | -$1.89K |
|
|
AVTA
587
DELISTED
Avantax, Inc. Common Stock
AVTA
| $39K | ﹤0.01% |
1,570
-196
| -11% | -$4.66K |
|
588
Black Hills Corp
BKH
$5.69B
| $38K | ﹤0.01% |
+701
| New | +$37.5K |
|
|
HI
589
DELISTED
Hillenbrand
HI
| $38K | ﹤0.01% |
823
+46
| +6% | +$2.07K |
|
590
Maximus
MMS
$3.1B
| $38K | ﹤0.01% |
565
+8
| +1% | +$544 |
|
591
Saic
SAIC
$5.35B
| $38K | ﹤0.01% |
488
-11
| -2% | -$830 |
|
|
TXNM
592
TXNM Energy Inc
TXNM
$5.94B
| $38K | ﹤0.01% |
995
+147
| +17% | +$5.38K |
|
|
NUVA
593
DELISTED
NuVasive, Inc.
NUVA
| $38K | ﹤0.01% |
+737
| New | +$37.4K |
|
|
BRSS
594
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $38K | ﹤0.01% |
1,135
+150
| +15% | +$4.76K |
|
595
Benchmark Electronics
BHE
$2.96B
| $37K | ﹤0.01% |
1,227
+105
| +9% | +$3.15K |
|
596
CACI
CACI
$14.2B
| $37K | ﹤0.01% |
247
-21
| -8% | -$3.07K |
|
597
Stepan Co
SCL
$1.48B
| $37K | ﹤0.01% |
447
+17
| +4% | +$1.35K |
|
|
PRFT
598
DELISTED
Perficient Inc
PRFT
| $37K | ﹤0.01% |
1,600
+413
| +35% | +$8.56K |
|
|
NXGN
599
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $37K | ﹤0.01% |
2,734
+344
| +14% | +$4.53K |
|
|
TEN
600
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $37K | ﹤0.01% |
+670
| New | +$38.2K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.